These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study. Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884 [TBL] [Abstract][Full Text] [Related]
4. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis. Weng Y; Liu Y; Benjoed C; Wu X; Tang S; Li X; Xie X; Lu W J Zhejiang Univ Sci B; 2022 Mar; 23(3):218-229. PubMed ID: 35261217 [TBL] [Abstract][Full Text] [Related]
5. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset. Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944 [TBL] [Abstract][Full Text] [Related]
6. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid. Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384 [TBL] [Abstract][Full Text] [Related]
7. [The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients]. Lin JJ; Jiang F; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1139-1145. PubMed ID: 36319461 [No Abstract] [Full Text] [Related]
8. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13. Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4). Jin T; Zhou Z; Lin M; Yuan S; Xue Y; Yin T; Xu R; Chen B; Zhang J; Sun J; Li X; Hu Y; Chen L; Wang H Am J Cancer Res; 2024; 14(3):1353-1362. PubMed ID: 38590416 [TBL] [Abstract][Full Text] [Related]
11. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5. Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643 [TBL] [Abstract][Full Text] [Related]
12. Treatment of low-risk gestational trophoblastic neoplasia. Winter MC Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():67-80. PubMed ID: 33741258 [TBL] [Abstract][Full Text] [Related]
13. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients. Qin J; Zhang S; Poon L; Pan Z; Luo J; Yu N; Wang L; Wu X; Cheng X; Xie X; Lu Y; Lu W Ultrasound Obstet Gynecol; 2021 May; 57(5):829-839. PubMed ID: 32385928 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and influence of lung metastasis on patient outcome in gestational trophoblastic neoplasia: A 10-year study at a single institution. Yu H; Li J; Zhu T; Xue X; Lu X Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():162-166. PubMed ID: 32505789 [TBL] [Abstract][Full Text] [Related]
15. Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017. Zhu CC; Liu HY; Wei Y; Shen Z; Qian LL; Song WG; Wang J; Wu DB; Zhang XF; Zhou Y Taiwan J Obstet Gynecol; 2019 May; 58(3):332-337. PubMed ID: 31122520 [TBL] [Abstract][Full Text] [Related]
16. Flat-dose versus weight or body surface area-based methotrexate dosing in low-risk gestational trophoblastic neoplasia. Parker VL; Cushen BF; Hills A; Kandiah K; Palmer JE; Singh K; Hancock BW; Tidy JA; Winter MC Gynecol Oncol; 2023 Feb; 169():34-40. PubMed ID: 36495594 [TBL] [Abstract][Full Text] [Related]
17. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia. Strohl AE; Lurain JR Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825 [TBL] [Abstract][Full Text] [Related]
18. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof]. Chen YX; Shen YM; Qian JH; Xie X Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819 [TBL] [Abstract][Full Text] [Related]
19. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital. Oranratanaphan S; Lertkhachonsuk R Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520 [TBL] [Abstract][Full Text] [Related]
20. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia. Rattanaburi A; Boonyapipat S; Supasinth Y Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]